The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Association of Transcription Factor APRF and Protein Kinase Jak1 with the Interleukin-6 Signal Transducer gp130
Abstract
Interleukin-6 (IL-6), leukemia inhibitory factor, oncostatin M, interleukin-11, and ciliary neurotrophic factor bind to receptor complexes that share the signal transducer gp130. Upon binding, the ligands rapidly activate DNA binding of acute-phase response factor (APRF), a protein antigenically related to the p91 subunit of the interferon-stimulated gene factor-3α (ISGF-3α). These cytokines caused tyrosine phosphorylation of APRF and ISGF-3α p91. Protein kinases of the Jak family were also rapidly tyrosine phosphorylated, and both APRF and Jak1 associated with gp130. These data indicate that Jak family protein kinases may participate in IL-6 signaling and that APRF may be activated in a complex with gp130.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both IFN␥ and IL-6 can activate JAK1 (4 -6) and JAK2 (7-10), and subsequently STAT1 (11,12) and STAT3 (6,13,14).”
From The Comparative Roles of Suppressor of Cytokine Signaling-1 and -3 in the Inhibition and Desensitization of Cytokine Signaling (2006) · cites this paper as [6]
Citations
Cites
Kessler, D. S., Veals, S. A., Fu, X. Y., & Levy, D. E. (1990) · Genes & Development · doi:10.1101/gad.4.10.1753 · Cited by 312
Flagged first, then by citations
Research works printed but not linked: 30
- 10.1016/0092-8674(93)90415-M · DOI
- BAZAN, J.F., NEUROPOIETIC CYTOKINES IN THE HEMATOPOIETIC FOLD, NEURON 7: 197 (1991). · DOI
- BAZAN, J.F., STRUCTURAL DESIGN AND MOLECULAR EVOLUTION OF A CYTOKINE RECEPTOR SUPERFAMILY, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 87: 6934 (1990).
- COOPER, J.A., DETECTION AND QUANTIFICATION OF PHOSPHOTYROSINE IN PROTEINS, METHODS IN ENZYMOLOGY 99: 387 (1983). · DOI
- 10.1126/science.8390097 · DOI
- DECKER, T, CYTOPLASMIC ACTIVATION OF GAF, AN IFN-GAMMA-REGULATED DNA-BINDING FACTOR, EMBO JOURNAL 10: 927 (1991). · DOI
- FIRMBACHKRAFT, I, TYK2, PROTOTYPE OF A NOVEL CLASS OF NONRECEPTOR TYROSINE KINASE GENES, ONCOGENE 5: 1329 (1990).
- FU, X.Y., TRANSCRIPTION FACTOR P91 INTERACTS WITH THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND MEDIATES ACTIVATION OF THE C-FOS GENE PROMOTER, CELL 74: 1135 (1993). · DOI
- 10.1126/science.1542794 · DOI
- HIBI, M, MOLECULAR-CLONING AND EXPRESSION OF AN IL-6 SIGNAL TRANSDUCER, GP130, CELL 63: 1149 (1990). · DOI · Paper page
- Hibi, M., Cell 63: 1149 (1990). · DOI · Paper page
- 10.1126/science.8378773 · DOI
- 10.1126/science.8511589 · DOI
- PATTERSON, P.H., NEURONAL DIFFERENTIATION FACTORS CYTOKINES AND SYNAPTIC PLASTICITY, CELL 72: 123 (1993). · DOI
- PELLEGRINI, S, EARLY EVENTS IN SIGNALING BY INTERFERONS, TRENDS IN BIOCHEMICAL SCIENCES 18: 338 (1993). · DOI
- 10.1126/science.8378774 · DOI
- 10.1126/science.8397445 · DOI
- SCHINDLER, C, PROTEINS OF TRANSCRIPTION FACTOR ISGF-3 - ONE GENE ENCODES THE 91-KDA AND 84-KDA ISGF-3 PROTEINS THAT ARE ACTIVATED BY INTERFERON-ALPHA, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 89: 7836 (1992).
- 10.1126/science.1496401 · DOI · Paper page
- 10.1126/science.1281555 · DOI
- 10.1126/science.7690989 · DOI · Paper page
- SILVENNOINEN, O, STRUCTURE OF THE MURINE JAK2 PROTEIN-TYROSINE KINASE AND ITS ROLE IN INTERLEUKIN-3 SIGNAL-TRANSDUCTION, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90: 8429 (1993).
- STAHL, N, THE ALPHAS, BETAS, AND KINASES OF CYTOKINE RECEPTOR COMPLEXES, CELL 74: 587 (1993). · DOI
- 10.1016/0092-8674(92)90105-L · DOI
- WEGENKA, U.M., ACUTE-PHASE RESPONSE FACTOR, A NUCLEAR FACTOR BINDING TO ACUTE-PHASE RESPONSE ELEMENTS, IS RAPIDLY ACTIVATED BY INTERLEUKIN-6 AT THE POSTTRANSLATIONAL LEVEL, MOLECULAR AND CELLULAR BIOLOGY 13: 276 (1993).
- WILKS, A.F., 2 NOVEL PROTEIN-TYROSINE KINASES, EACH WITH A 2ND PHOSPHOTRANSFERASE-RELATED CATALYTIC DOMAIN, DEFINE A NEW CLASS OF PROTEIN-KINASE, MOLECULAR AND CELLULAR BIOLOGY 11: 2057 (1991).
- WITTHUHN, B.A., JAK2 ASSOCIATES WITH THE ERYTHROPOIETIN RECEPTOR AND IS TYROSINE-PHOSPHORYLATED AND ACTIVATED FOLLOWING STIMULATION WITH ERYTHROPOIETIN, CELL 74: 227 (1993). · DOI
- YOSHIMURA, A, INVITRO PHOSPHORYLATION OF THE ERYTHROPOIETIN RECEPTOR AND AN ASSOCIATED PROTEIN, PP130, MOLECULAR AND CELLULAR BIOLOGY 12: 706 (1992).
- Yuan, J., Molecular and Cellular Biology 14: 1657 (1994).
- Ip, N. Y., Cell 69: 1121 (1992). · DOI
Cited by
Sorted by citations
Items 601–700 of 704
Roth, C. M., Kohen, R., Walton, S., & Yarmush, M. (2001) · Biophysical Chemistry · doi:10.1016/s0301-4622(00)00212-x · Cited by 9
Korostensky, C., Staudenmann, W., Dainese, P., Hoving, S., Gonnet, G., & James, P. (1998) · Electrophoresis · doi:10.1002/elps.1150191111 · Cited by 9
Chapter 1 Molecular aspects of prolactin and growth hormone receptors
Goffin, V., Ferrag, F., & Kelly, P. (1998) · doi:10.1016/s1569-2566(98)80009-4 · Cited by 9
Lung cancer treatment potential and limits associated with the STAT family of transcription factors
Faida, P., Attiogbe, M. K. I., Majeed, U., Zhao, J., Qu, L., & Fan, D. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110797 · Cited by 6
Hsiao, J. J., Ng, B. H., Smits, M. M., Martinez, H. D., Jasavala, R. J., Hinkson, I. V., Fermin, D., Eng, J. K., Nesvizhskii, A. I., & Wright, M. E. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1021 · Cited by 8
Proinflammatory Stem Cell Signaling in Cardiac Ischemia
Herrmann, J. L., Markel, T. A., Abarbanell, A. M., Weil, B. R., Wang, M., Wang, Y., Tan, J., & Meldrum, D. R. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2434 · Cited by 8
“The gp130 molecule transduces the signal through interaction with the tyrosine kinases known as the Janus kinases ( Jak 1, Jak2, and Tyk2) (88, 129).”
STAT3 and SMAD1 Signaling in Medaka Embryonic Stem-Like Cells and Blastula Embryos
Wagner, T. U., Kraeussling, M., Fedorov, L. M., Reiss, C., Kneitz, B., & Schartl, M. (2008) · Stem Cells and Development · doi:10.1089/scd.2007.0262 · Cited by 7
“Upon activation of the cytokine receptor common subunit gp130 [6], STAT3 monomers attach to a YXXQ motive [7,8] and become activated through phosphorylation of tyrosine 705 [9] by the receptor associated janus kinase JAK1 [10].”
Gene expression, biological effects and clinical aspects of lymphokines.
Tuyt, L., Dokter, W., & Vellenga, E. (1997) · Critical reviews in oncology/hematology · doi:10.1016/s1040-8428(97)10006-3 · Cited by 8
Receptor to nucleus signaling via tyrosine phosphorylation of the p91 transcription factor.
Daly, C., & Reich, N. (1994) · Trends in endocrinology and metabolism · doi:10.1016/1043-2760(94)90013-2 · Cited by 8
Overview of cytokines and receptors in Silicosis
Tripathi, S. S., Pandey, H. P., & Paul, B. (2011) · doi:10.7324/japs.2011.105.76 · Cited by 7
“Activation of Jak1, 2 and Tyk2 (Tyrosine kinase 2 ) by IL-6 results in the phosphorylation and activation of STAT-3 and, to much lesser extent, STAT-1 leading to the induction of IL-6 responsive gene expression (Lutticken et al, 1994; Stahl et al, 1994; Akira et al, 1994;Nakajima et al, 1995).”
Müller-Newen, G., Pflanz, S., Hassiepen, U., Stahl, J., Wollmer, A., Heinrich, P. C., & Grötzinger, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00425.x · Cited by 7
Self-citationDevelopment of Human IL‐6 Receptor Antagonists
Brakenhoff, J., Hon, F. D., & Aarden, L. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb32321.x · Cited by 7
Molecular Facets of Pluripotency
Cavaleri, F. M., & Schöler, H. R. (2004) · Elsevier eBooks · doi:10.1016/b978-012436643-5/50012-2 · Cited by 8
Prado, D. D. S., Kutuva, A. R., Cattley, R. T., Sonego, A. B., Sutariya, P., Elbushra, I. M., Wu, S., Lee, M., Cumberland, R. L., Mehta, I. D., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03591-4 · Cited by 8
The Effects of Silibinin Combined With EGFR ‐ TKIs in the Treatment of NSCLC
Wang, X. (2025) · Cancer Medicine · doi:10.1002/cam4.70643 · Cited by 5
Tocilizumab in Pediatric Rheumatology: The Clinical Experience
Gurion, R., & Singer, N. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-013-0338-y · Cited by 6
Localization of molecules involved in cytokine receptor signaling in the rat trigeminal ganglion.
Mizuno, M., Kondo, E., Nishimura, M., Ueda, Y., Yoshiya, I., Tohyama, M., & Kiyama, H. (1997) · Brain Research. Molecular Brain Research · doi:10.1016/s0169-328x(96)00283-5 · Cited by 6
Novel STAT3 variant causing infantile-onset autoimmune disease
Pan, M., & Kurtz, J. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1251088 · Cited by 5
Antibodies to rat soluble IL‐6 receptor stimulate B9 hybridoma cell proliferation
Thibault, V., Richards, C. D., Botelho, F., & Gauldie, J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00417-1 · Cited by 5
Dewanjee, M., Belinskiy, V., Holland, J. F., Kapadvanjwala, M., Wu, S.-M., Novak, S., Hsu, L., Sánchez, J., Dewanjee, S., Serafini, A., et al. (2004) · Journal of Thrombosis and Thrombolysis · doi:10.1007/bf00181662 · Cited by 5
“The synthesis of E-selectin is initiated by cytokine stimulation and peaks in 4-6 hours [17,26,29,30].”
BackgroundSTATs in the Central Nervous System
Bonni, A. (2003) · Springer eBooks · doi:10.1007/978-94-017-3000-6_42 · Cited by 2
Hampel, H., Scheloske, M., & Haslinger, A. (2001) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8350-4_6 · Cited by 5
Yoshida, K., Taga, T., Saito, M., Kumanogoh, A., Tanaka, T., Ozono, K., Nakayama, M., Nakahata, T., Yoshida, N., & Kishimoto, T. (1998) · doi:10.1007/978-1-4757-2753-1_16 · Cited by 5
Self-citationLeukemia inhibitory factor and its receptor
Nicola, N. A., & Hilton, D. J. (1997) · Growth factors and cytokines in health and disease · doi:10.1016/s1874-5687(97)80037-7 · Cited by 5
The Hematopoietic Cytokine Receptors
O'Farrell, A.-M., Kinoshita, T., & Miyajima, A. (1996) · Blood cell biochemistry · doi:10.1007/978-0-585-31728-1_1 · Cited by 5
Novel targets for treating neurodegenerative diseases: The PKM2-STAT3-hnRNPA1 feedback loop
Ye, P., Li, Z., & Jiang, H. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107840 · Cited by 4
Evaluating the IL‐6 Family of Cytokines Throughout Equine Gestation
Fedorka, C. E., Scoggin, K. E. S., Ali, H. E., & Troedsson, M. H. T. (2024) · American Journal of Reproductive Immunology · doi:10.1111/aji.13910 · Cited by 4
Zhou, Y., Xu, Z., & Li, S. (2022) · Aging · doi:10.18632/aging.204126 · Cited by 5
Costantini, F., Leo, F. D., Sano, C. D., Fiore, T., Pellerito, C., & Barbieri, G. (2019) · Cells · doi:10.3390/cells8121547 · Cited by 4
“Finally, we showed the inhibition of the STAT3 expression, a key protein implicated in the regulation of growth, survival, invasion, migration and metastatic spread of tumour cells [53].”
BackgroundSelf-citationClay, T. D., Russell, P. A., Do, H., Sundararajan, V., Conron, M., Wright, G. M., Solomon, B., Dobrovic, A., McLachlan, S., & Moore, M. M. (2017) · Medical Oncology · doi:10.1007/s12032-017-1031-1 · Cited by 5
Katoh, D., Nishizuka, M., Osada, S., & Imagawa, M. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-01026 · Cited by 4
Yamauchi-Takihara, K., Hirota, H., Kunisada, K., Matsui, H., Fujio, Y., Taga, T., & Kishimoto, T. (1996) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(96)80060-1 · Cited by 4
Self-citationInsights from Interleukin-6 trans-signaling and implications for the control of cytokine activity
Rose‐John, S. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2026.120109 · Cited by 3
Lin, X., Korai, A., Nakazawa, Y., Tago, K., & Funakoshi-Tago, M. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112128 · Cited by 3
Review of Janus Kinase Inhibitors as Therapies for Noninfectious Uveitis
Hui, Y.-J., Sheu, S., & Hwang, D.-K. (2024) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2024.0100 · Cited by 3
Masjkur, J., Levenfus, I., Lange, S., Arps-Forker, C., Poser, S., Qin, N., Vukićević, V., Chavakis, T., Eisenhofer, G., Bornstein, S., et al. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0211 · Cited by 3
Jacques, Y., Minvielle, S., Müller-Newen, G., Heinrich, P., Grötzinger, J., Montero-Julian, F., Brailly, H., Wilkin, J., & Content, J. (1998) · Research in Immunology · doi:10.1016/s0923-2494(99)80049-2 · Cited by 3
Self-citation(1996) · doi:10.1111/j.1600-0463.1996.tb05576.x · Cited by 3
Smit, L. S., & Carter-Su, C. (1996) · doi:10.1016/s1874-5687(96)80005-x · Cited by 3
Yang, Y.-C. (1995) · Cancer treatment and research · doi:10.1007/978-1-4613-1241-3_13 · Cited by 3
Tyrosine kinases in megakaryocytopoiesis
Avraham, H., Ellis, M. H., Jhun, B., Raja, S., Chalasani, D., & Avraham, S. (1995) · Stem Cells · doi:10.1002/stem.5530130409 · Cited by 3
Seibel, C., Pudewell, S., Rafii, P., Ettich, J., Weitz, H. T., Lang, A., Petzsch, P., Köhrer, K., Floss, D. M., & Scheller, J. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156766 · Cited by 3
[Role of STAT3 in Resistance of Non-small Cell Lung Cancer].
Sun, S., Jin, S., & Guo, R. (2019) · Europe PMC (PubMed Central) · doi:10.3779/j.issn.1009-3419.2019.07.08 · Cited by 4
Involvement of stat3 in mouse brain development and sexual dimorphism: A proteomics approach
Domenico, F. D., Casalena, G., Rukhsana Sultana, A., Cai, J., Pierce, W. M. J., Marzia Perluigi, A., Cini, C., Baracca, A., Solaini, G., Lenaz, G., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.09.074 · Cited by 21
“Indeed, it appears to have pleiotropic activity relevant also to cell survival and differentiation (Levy and Darnell, 2002; Levy and Lee, 2002; Lutticken et al., 1994).”
The role of circulating cytokines in colorectal carcinoma
Siragusa, T., Miller, A., Belluco, C., Nitti, D., Lise, M., & Jessup, J. (2000) · International Journal of Clinical Oncology · doi:10.1007/pl00012041 · Cited by 2
gp130-mediated signalling as a therapeutic target
Ohtani, T., Ishihara, K., Atsumi, T., Yoshida, Y., Nishida, K., Narimatsu, M., Shirogane, T., Hibi, M., & Hirano, T. (2000) · Emerging Therapeutic Targets · doi:10.1517/14728222.4.4.459 · Cited by 2
“The binding of IL-6 to the receptor induces the homodimerisation of gp130, leading to the activation of the associated JAKs, including JAK1, JAK2 and Tyk2 [13]. gp130 is a single transmembrane glycoprotein with a molecular mass of 130 - 150 kDa [12].”
BackgroundIsoprenoids, Ras and proliferative glomerular disease.
O'Donnell, M. P., Massy, Z. A., Guijarro, C., Kasiske, B., Kim, Y., & Keane, W. F. (1997) · Contributions to Nephrology · doi:10.1159/000059840 · Cited by 2
Embryonic Stem Cells: Derivation and Properties
Yu, J.-Y., & Thomson, J. (2011) · doi:10.1016/b978-0-12-381422-7.10010-0 · Cited by 2
Taga, T., Yoshida, K., Hirota, H., & Kishimoto, T. (1996) · doi:10.1007/978-4-431-68320-9_13 · Cited by 2
Self-citationDirect Signal Transduction by Tyrosine Phosphorylation of Transcription Factors with SH2 Domains
Fu, X.-Y. (1995) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4684-6837-3_4 · Cited by 2
Vein graft failure: Pathophysiology, detection, prevention and emerging therapeutic strategies
Brown, S. M., Sánchez, S. G., Clark, L., Miteva, K., Krilis, G., Forsythe, R. O., Nicklin, S. A., Carmichael, S., Berry, C., Al‐Attar, N., et al. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100139 · Cited by 1
“201 Phos-phorylated gp130 creates docking sites for the downstream signal transduction molecules, including STAT-3.”
Research progress of oxidative stress in sepsis-associated liver injury
Fang, S.-P., Su, H., Xu, T.-Y., Sun, R., Xiang, Y., Gao, Y., & Zai, K. (2024) · Perioperative Precision Medicine · doi:10.61189/270899wnwlnz · Cited by 1
“When IL-6 and other cytokines bind to the relevant receptors, they can change the molecular conformation of the receptor [41].”
Identification of de novo STAT3 target gene in liver regeneration
Zhang, H., Haga, S., Fukai, M., Oikawa, Y., Inoue, H., Ogawa, W., Kano, A., Maruyama, A., Fu, X.-Y., Todo, S., et al. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00278.x · Cited by 2
NF-Y regulates LIF-induced transcription of the signaling adaptor SKAP55R in myeloid cells
Curtis, D., Dougherty, L., & Bodine, D. (2001) · Leukemia · doi:10.1038/sj.leu.2402286 · Cited by 1
Starr, R. (2000) · CRC Press eBooks · doi:10.1201/9780203904244.ch10 · Cited by 1
Activation of cellular responses to interleukin 6 is blocked by staurosporine
Peppard, J. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00083-1 · Cited by 1
Signal Pathways from the Plasma Membrane to the Nucleus Regulating Craniofacial Pattern Formation
Meyer, T. (2021) · Springer eBooks · doi:10.1007/978-3-030-46024-2_3
The role of Raf kinase inhibitory protein in inflammation
Shenouda, S., Bosso, M., Ahmad, R., & Al‐Mulla, F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819612-0.00016-x · Cited by 1
Transcription Factors STAT5 and STAT3
Čulig, Z., Pestell, R. G., & Nevalainen, M. T. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-079-3_12 · Cited by 1
Endokrine Funktionen II: Zytokine
Heinrich, P., Schaper, F., Timmermann, A., Martens, A. S., & Lehmann, U. (2003) · Springer-Lehrbuch · doi:10.1007/978-3-662-06058-2_28 · Cited by 1
Self-citationSTAT-Dependent Gene Expression without Tyrosine Phosphorylation
Chatterjee‐Kishore, M., Yang, J. B., & Stark, G. R. (2003) · Springer eBooks · doi:10.1007/978-94-017-3000-6_23 · Cited by 1
Mechanisms and Biological Roles of STAT Activation by the IL-6 Family of Cytokines
Kamimura, D., & Hirano, T. (2003) · Springer eBooks · doi:10.1007/978-94-017-3000-6_11 · Cited by 1
Le CNTF, une cytokine gliale au secours des neurones.
Monville, C., & Peschanski, M. (2001) · doi:10.4267/10608/1969 · Cited by 1
Shoyab, M., Malik, N., & Wallace, P. M. (1998) · doi:10.1016/b978-012498340-3/50028-2 · Cited by 1
Cytokines and Their Receptors in the Peri-implantation Endometrium
Harper, M. J. (1997) · doi:10.1007/978-3-662-10323-4_5 · Cited by 1
Stahl, N., & Yancopouloš, G. (1997) · doi:10.1016/s1874-5687(97)80040-7 · Cited by 1
Leukemia inhibitory factor and phenotypic specialization
Yamamori, T. (1996) · Elsevier eBooks · doi:10.1016/b978-044482529-2/50033-0 · Cited by 1
Inducible Gene Expression, Volume 2
Baeuerle, P. (1995) · Progress in Gene Expression · doi:10.1007/978-1-4684-6837-3 · Cited by 1
CHAPTER 12 – CELLULAR ACTIVATION
Gold, M. (1994) · Elsevier eBooks · doi:10.1016/b978-0-12-208885-8.50018-1 · Cited by 1
Resveratrol as a Dual MAPK/STAT3 Inhibitor in Glioblastoma: Mutation-Dependent Therapeutic Efficacy
Ullah, A., Li, M.-J., Aljasir, M., Ahmad, S., & Han, C.-C. (2026) · Life · doi:10.3390/life16050772
Jang, H., Kang, Y., Park, E.-J., Park, E., Kim, W., Lee, S., & Lee, S. (2026) · Biomedical Reports · doi:10.3892/br.2026.2108
JAK/STAT Signalling Overdrive in Immune Regulation: A Trigger for Autoimmunity
Cyriac, K. S., & N, H. (2024) · International journal of pharmaceutical sciences review and research · doi:10.47583/ijpsrr.2024.v84i06.005
“And the signaling in reaction to adhering of IL-6,11, leukaemia inhibitory factor to the type I receptor common glycoprotein 130 chain occurs via JAK1, 2 and TYK2 24”
BackgroundBehrendsen, L. S., Menon, P., Khan, M. J., Gregus, A., Wirths, O., Meyer, T., & Staab, J. (2022) · BMC Molecular and Cell Biology · doi:10.1186/s12860-022-00422-9
Griesenauer, B. (2018) · IUScholarWorks (Indiana University) · doi:10.7912/c2sk9v
The role of LIF-STAT3 signaling in maintaining self-renewal and pluripotent state and in rat cells
Vaskova, E. A., Sherstyuk, V. V., & Zakian, S. (2016) · Genes & Cells · doi:10.23868/gc120576
Targeting Neuropilin-1 in Prostate Cancer Bone Metastasis
Wu, D. (2010) · Defense Technical Information Center (DTIC) · doi:10.21236/ada538180
Interleukine-6 : une cible potentielle pour le syndrome post-thrombotique
Wojcik, B. M., Wrobleski, S., Hawley, A., Wakefield, T., Myers, D., & Diaz, J. (2011) · Annales de Chirurgie Vasculaire · doi:10.1016/j.acvfr.2011.12.013
“and TYK2, are constitutively associated with the cytoplasmic tail of gp130 and phosphorylate gp130 dimers (6, 7).”
BackgroundEditorial: Calcium, cytokines, and maturation factors during T cell activation
Hass, R. (2006) · Signal Transduction · doi:10.1002/sita.200690027
Die Regulation des humanen Lipopolysaccharid bindenden Proteins (hLBP)
Hallatschek, W. (2005) · doi:10.18452/15202
“Der zweite Weg führt über die Tyrosinphosphatase SHP2 und die MAP-Kinasen, die ebenfalls die Stats aktivieren können, zu den Transkriptionsfaktoren der C/EBP Familie [95, 96, 97].”
BackgroundImmune Function and Regulation of the Autonomic Nervous System
Rivest, S. (2002) · CRC Press eBooks · doi:10.1201/9780203908891.ch2
Ravi, V., Bergtrom, K. G., & Amrani, L. (1998) · doi:10.1016/s0268-9499(98)80298-1
Signal Transduction into the Nucleus: Fifth Colloquium on Cellular Signal Transduction
Marks, F., & Angel, P. (1996) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01221198
RED-HOT RESEARCH PAPERS OF 1994
Holden, C. (1995) · Science · doi:10.1126/science.267.5198.619-a
Salk Gets Crick Permanently ... Sort Of
Holden, C. (1995) · Science · doi:10.1126/science.267.5198.619-b
Biochemie und Molekulargenetik 1994
Schomburg, D., & Niefind, K. (1995) · Nachrichten aus Chemie Technik und Laboratorium · doi:10.1002/nadc.19950430210
Robinson, R. C. (1994) · Cell · doi:10.1016/0092-8674(94)90449-9 · Cited by 213
Bongartz, H. (2017) · doi:10.25673/5221
“Diese Box-Motive vermitteln die Interaktion von gp130 mit den Tyrosinkinasen der Janus Kinase-Familie (Jak) Jak1, Jak2 oder Tyk2 [27, 28, 29].”
BackgroundMartincuks, A. (2017) · RWTH Publications (RWTH Aachen) · doi:10.18154/rwth-2017-01944
“In 1994 the laboratory of Friedemann Horn at the Institute for Biochemistry at RWTH Aachen, where this thesis was written, in parallel with the Kishimoto group identified and cloned the acute phase response factor (APRF) which is activated by interleukin-6 (IL-6) [12, 13].”
BackgroundQuantitative proteomics of androgen receptor-mediated signaling networks in prostate tumor cells
Hsiao, J. J. (2015) · doi:10.17077/etd.sncryyz9
“The adaptors TAB3 and TRAF3 are downstream components of the Tumor necrosis factor (TNF) pathway (227-229), TAB3 and the protein kinase JAK1 are major regulators of the IL-R receptor signaling pathway (227,230), the adaptor SHOC2 is a known component of the EGF signaling pathway (231,232), and ABL1 is a”
BackgroundNuclear Factors Linking Cancer and Inflammation
Chosdol, K., Bhagat, M., Dikshit, B., Madan, E., Chattopadhyay, P., & Sinha, S. (2013) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-8039-6_6
Chapter 22 – Embryonic Stem Cells: Derivation and Properties
Yu, J.-Y., & Thomson, J. (2013) · doi:10.1016/b978-0-12-385942-6.00022-6
Mixture models for analysing high throughput sequencing data
Zhang, X.-K. (2011) · doi:10.14288/1.0105109
“Cytokine stimulation induces members of the STAT transcription factor family, Stat1 and Stat3, to ‘dock’ onto receptor phosphotyrosines, enabling their own tyrosine phosphorylation [11, 83, 121].”
BackgroundTranscription Factors Stat5a/b and Stat3 in Prostate Cancer Growth and Metastases
Mirtti, T. K., Talati, P. G., & Nevalainen, M. T. (2011) · Springer eBooks · doi:10.1007/978-94-007-2558-4_10
Kommunikation zwischen Zellen: Extrazelluläre Signalmoleküle, Rezeptoren und Signaltransduktion
Heinrich, P., Haan, S., Hermanns, H. M., Löffler, G., Müller-Newen, G., & Schaper, F. (2007) · Springer-Lehrbuch · doi:10.1007/978-3-540-32681-6_25
Self-citationAdvances in management of malignancies
Haana, S., Harrisb, K. W., Hermannsa, H. M., Metza, S., Müller-Newena, G., Schapera, F., & Wiesingera, M. (2006) · doi:10.1016/j.biopha.2006.07.057
“Our laboratory has elucidated the molecular mechanism by which IL-6, IL-11, IL-31, oncostatin-M and leukemia inhibitory factor signal from the plasma membrane to the cell nucleus [1].”
BackgroundStructural Bases of Receptor-JAK-STAT Interactions
Heinrich, P. C., Behrmann, I., Haan, S., Hermanns, H. M., Müller‐Newen, G., & Schaper, F. (2003) · Springer eBooks · doi:10.1007/978-94-017-3000-6_4
Self-citationCell Signaling by Hematopoietic Growth Factor Receptors
Starr, R., & Nicola, N. (1999) · Elsevier eBooks · doi:10.1016/b978-012624960-6/50004-2
Metadata
- Authors
- Lütticken, C., Wegenka, U. M., Yuan, J., Buschmann, J., Schindler, C., Ziemiecki, A., Harpur, A. G., Wilks, A. F., Yasukawa, K., Taga, T., Kishimoto, T., Barbieri, G., Pellegrini, S., Sendtner, M., Heinrich, P. C., & Horn, F.
- Affiliations
- RWTH Aachen University (DE)
- ORCID
- Venue
- Science
- Published
- 1994-01-07
- Volume
- 263
- Issue
- 5143
- Pages
- 89-92
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1999028040
- Cited by
- 814
- References
- 0
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 11 · 2023: 5 · 2022: 7 · 2021: 13 · 2020: 10 · 2019: 14 · 2018: 14 · 2017: 17 · 2016: 17 · 2015: 23 · 2014: 15 · 2013: 15 · 2012: 20
- FWCI
- 38.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- JAK1, gp130, IL-6 signaling, cytokine-receptor complex, tyrosine phosphorylation, transcription factor activation, leukemia inhibitory factor, oncostatin M, interleukin-11, ciliary neurotrophic factor, signal transduction
- MeSH terms
- Base Sequence, DNA-Binding Proteins, Humans, Interferon-gamma, Membrane Glycoproteins, Molecular Sequence Data, Phosphorylation, Protein-Tyrosine Kinases, Transcription Factors, Tumor Cells, Cultured, Tyrosine, Signal Transduction, Trans-Activators, Antigens, CD, Interleukin-6, Cytokines, STAT1 Transcription Factor, STAT3 Transcription Factor, Cytokine Receptor gp130, Interferon-Stimulated Gene Factor 3, Interferon-Stimulated Gene Factor 3, gamma Subunit, Janus Kinase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review